Topics

High-grade gliomas | Treatment | Clinical trials | Viruses

Home > Publications > Topics > High-grade gliomas > Treatment > Clinical trials > Viruses

Ning W, Qian X, Dunmall LC, Liu F, Guo Y, Li S, Song D, Liu D, Ma L, Qu Y, Wang H, Gu C, Zhang M, Wang Y, Wang S, Zhang H.
Non-secreting IL12 expressing oncolytic adenovirus Ad-TD-nsIL12 in recurrent high-grade glioma: a phase I trial.
Nat Commun. 2024 Nov 8;15(1):9299. doi: 10.1038/s41467-024-53041-7. PMID: 39516192. Interventional study. ˍ

Zeng W, Wang P, Fang S, Ge S, Jia W, Peng S, Wang M, Qin X, Zhang W, Gao J, Su X, Yuan G, Wu J, Liu Y, Wang Y, Lu H, Mu R, Wu F, Chang Q, Jin G, Meng F, Zhang J, Liu F.
ON-01, an engineered recombinant oncolytic herpes simplex virus type-1, in recurrent glioma: a single-arm, phase 1/2 study.
Neuro Oncol. 2026 Jan 12:noag005. doi: 10.1093/neuonc/noag005. PMID: 41527280. Interventional study. ˍ